Please note: This website has recently moved from www.health.gov to odphp.health.gov. www.health.gov is now the official website of ODPHP’s parent organization, the Office of the Assistant Secretary for Health (OASH). Please update your bookmarks for easy access to all our resources. 

Increase the proportion of people with substance use and mental health disorders who get treatment for both — MHMD‑07 Data Methodology and Measurement

About the National Data

Data

Baseline: 17.0 percent of adults aged 18 years and over with co-occurring substance use disorders and mental health disorders received both mental health care and specialty substance use treatment in 2022

Target: 19.7 percent

Numerator
Number of adults aged 18 years and over with co-occurring substance use and mental disorders who receive both mental health treatment and specialty substance use treatment.
Denominator
Number of adults aged 18 years and over with co-occurring substance use and mental disorders.
Target-setting method
Minimal statistical significance
Target-setting method details
Minimal statistical significance, assuming the same standard error for the target as for the baseline.
Target-setting method justification
Trend data were not available for this objective. The standard error was used to calculate a target based on minimal statistical significance, assuming the same standard error for the target as for the baseline. This method was used because it was a minimal statistically significant improvement from the baseline.

Methodology

Questions used to obtain the national baseline data

(For additional information, please visit the data source page linked above.)

Please refer to the “Substance Dependence and Abuse” module, “Alcohol and Drug Treatment” module, and “Mental Health Services Utilization” module of the “2022 National Survey on Drug Use and Health (NSDUH): Final CAI Specifications for Programming” for the baseline questions of substance use disorder, substance use treatment and mental health treatment respectively.

Methodology notes

Substance use disorder (SUD) was defined as meeting criteria in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), for one or more drugs or alcohol.
Any mental illness (AMI) among adults was defined as adults aged 18 or older who currently or at any time in the past year have had a diagnosable mental, behavioral, or emotional disorder as defined above, regardless of the level of impairment in carrying out major life activities. AMI was estimated based on a statistical model of a clinical diagnosis and responses to questions in the main NSDUH interview on distress (Kessler-6 scale), impairment (truncated version of the World Health Organization Disability Assessment Schedule), past year major depressive episode, past year suicidal thoughts, and age.


Mental health treatment in the past year was defined as the receipt of treatment or counseling for any problem with mental health, emotions, or behavior in the 12 months prior to the interview. Respondents were asked in the mental health services utilization section of the questionnaire to report whether they received mental health treatment in the past 12 months in an inpatient location, in an outpatient location, through the use of prescription medication, via telehealth treatment, or in a prison, jail, or juvenile detention center.


Respondents were classified as having received substance use treatment if they reported in the alcohol and drug treatment section of the questionnaire that they received treatment in the past 12 months for their use of alcohol or drugs in an inpatient location, in an outpatient location, via telehealth, or in a prison, jail, or juvenile detention center or that they received medication-assisted treatment for alcohol use or opioid use.

History

Comparable HP2020 objective
Modified, which includes core objectives that are continuing from HP2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
The National Survey on Drug Use and Health adopted a multimode data collection method in 2021. Due to this change, data starting in 2021 are not comparable to those from earlier years. Additionally, the mental health treatment questions on the National Survey on Drug Use and Health underwent considerable revisions in the 2022 survey. Due to these changes, the 2022 estimates for mental health treatment cannot be compared with estimates from 2021 or earlier years.
Revision History
Revised. 

In 2024, due to the NSDUH adopting a multimode data collection method in 2021 and due to considerable revisions made to the mental health treatment questions on the 2022 survey, the baseline was revised from 3.4% in 2018 to 17.0% in 2022. The target was revised from 8.2% to 19.7% using the original target setting method.